| Financial Year |
March 31 2023 |
| Monetary Funds |
120,606,263.89 |
| Held-for-trading Financial Assets |
332,601,306.26 |
| Notes Receivable |
16,177,535.15 |
| Accounts Receivable |
403,103,344.29 |
| Advances to Suppliers |
11,648,907.66 |
| Other Receivables |
1,154,470.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
131,457,212.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
14,146,404.04 |
| Other Current Assets |
496,102,155.37 |
| Total Current Assets |
1,529,869,966.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
61,345,487.90 |
| Under-construction Projects |
129,457,094.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,976,156.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,433,065.85 |
| Deferred Income Tax Assets |
22,776,904.64 |
| Other Non-Current Assets |
92,774,697.09 |
| Sub-Total of Non-Current Assets |
335,372,594.07 |
| Total Assets |
1,865,242,560.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,372,032.63 |
| Accounts Payable |
64,676,350.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,889,084.97 |
| Taxes Payable |
11,526,166.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,522,030.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,042,038.07 |
| Other Current Liabilities |
1,278,885.89 |
| Sub-Total of Current Liabilities |
203,107,855.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,430,194.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,034,203.78 |
| Total Liabilities |
206,142,059.51 |
| Paid-In Capital(Or Share Stock) |
74,390,000.00 |
| Capital Surplus |
994,462,565.77 |
| Surplus Reserve |
42,608,360.08 |
| LESS:Treasury Stock |
14,089,000.00 |
| Undistributed Profits |
561,192,643.75 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,659,100,500.72 |
| Owner's Equity（Stockholder's Equity） |
1,659,100,500.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,865,242,560.23 |
